Are we lowering LDL cholesterol sufficiently?

被引：3

作者：

Barter, Philip ^{[1
]}

Rye, Kerry-Anne ^{[1
]}

机构：

[1] Heart Res Inst, Lipid Res Grp, Sydney, NSW 2050, Australia

来源：

NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2006年 / 3卷 / 06期

关键词：

D O I：

10.1038/ncpcardio0555

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：290 / 291

页数：2

共 10 条

[1] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[2] Risk for myopathy with statin therapy in high-risk patients [J].

Ballantyne, CM ;

Corsini, A ;

Davidson, MH ;

Holdaas, H ;

Jacobson, TA ;

Leitersdorf, E ;

März, W ;

Reckless, JPD ;

Stein, EA .

ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (05) :553-564

[3] Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].

Cannon, CP ;

Braunwald, E ;

McCabe, CH ;

Rader, DJ ;

Rouleau, JL ;

Belder, R ;

Joyal, SV ;

Hill, KA ;

Pfeffer, MA ;

Skene, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504

[4]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[5] Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [J].

Grundy, SM ;

Cleeman, JI ;

Merz, CNB ;

Brewer, HB ;

Clark, LT ;

Hunninghake, DB ;

Pasternak, RC ;

Smith, SC ;

Stone, NJ .

CIRCULATION, 2004, 110 (02) :227-239

[6] Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial) [J].

Jones, PH ;

Davidson, MH ;

Stein, EA ;

Bays, HE ;

McKenney, JM ;

Miller, E ;

Cain, VA ;

Blasetto, JW ;

STELLAR Study Grp .

AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (02) :152-160

[7]

LaRosa JC, 2005, CIRCULATION, V112, pU726

[8] Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J].

LaRosa, JC ;

Grundy, SM ;

Waters, DD ;

Shear, C ;

Barter, P ;

Fruchart, J ;

Gotto, AM ;

Greten, H ;

Kastelein, JJP ;

Shepherd, J ;

Wenger, NK .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) :1425-1435

[9] Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial [J].

Nissen, SE ;

Tuzcu, EM ;

Schoenhagen, P ;

Brown, BG ;

Ganz, P ;

Vogel, RA ;

Crowe, T ;

Howard, G ;

Cooper, CJ ;

Brodie, B ;

Grines, CL ;

DeMaria, AN .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09) :1071-1080

[10] High-dose atorvastatin vs usual dose simvastatin for secondary prevention after myocardial infarction - The IDEAL study: A randomized controlled trial [J].

Pedersen, TR ;

Faergeman, O ;

Kastelein, JJP ;

Olsson, AG ;

Tikkanen, MJ ;

Holme, I ;

Larsen, ML ;

Bendiksen, FS ;

Lindahl, C ;

Szarek, M ;

Tsai, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (19) :2437-2445

← 1 →